Botanicals and cardiometabolic risk: positioning science to address the hype

Metabolism: Clinical and Experimental

Volumn 57, Issue SUPPL. 1, 2008, Pages

  Cefalu, William T ^a   Brantley, Phillip J ^a  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLANT EXTRACT;

BLOOD CLOTTING DISORDER; CALORIC RESTRICTION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIET SUPPLEMENTATION; DNA SEQUENCE; DYSLIPIDEMIA; EDITORIAL; EPIGENETICS; GENE EXPRESSION; GENETIC DISORDER; GLUCOSE INTOLERANCE; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; INFLAMMATION; INSULIN RESISTANCE; LIFESTYLE; MEDICAL RESEARCH; MEDICINAL PLANT; METABOLIC SYNDROME X; MORBIDITY; MORTALITY; NUTRITIONAL SUPPORT; OBESITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RISK ASSESSMENT; UNITED STATES;

ANIMALS; CARDIOVASCULAR DISEASES; HUMANS; METABOLIC DISEASES; PLANT EXTRACTS; RESEARCH; RISK FACTORS;

EID: 44949262175     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2008.04.002     Document Type: Editorial

References (4)

1. Nissen S.E., and Wolski K. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med 356 (2007) 2457-2471
2. Swanson C.A., and Liu Q.Y. Introduction to the national institutes of health botanical research centers program. Am J Clin Nutr 87 (2008) 471S
3. http://dietary-supplements.info.nih.gov/Research/Dietary_Supplement_Research_Centers.aspx.
4. The science of botanical supplements for human health: A view from the NIH Botanical Research Centers. AJCN 87 Suppl (2008) 465S-513S